Observational studyMedicine2019

Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting.

Jiao Leng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.